We further performed Immunohistochemical analysis to investigate the effects of PLPP4 on the tumorigenic activity of the glioma and PAAD patients and found that PLPP4 showed high expression in the glioma and PAAD patients. The gene discussed is PLPP4; the disease is pancreatic adenocarcinoma.